Patent US5011687A successfully refreshed from Google Patents.
US5011687A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Purified Mullerian inhibiting substance and process for treating human ovarian cancer cells
Assignee: General Hospital Corp
•
Filing: 1985-10-29
•
Granted: 1991-04-30
•
Expires: 2005-10-29
Abstract
Abstract Purified Mullerian inhibiting substance (MIS) is obtained from testicular tissue by extraction, density gradient sedimentation and chromatography. The purified MIS has selective activity for inhibiting the growth of human ovarian cancer cells.
Inventors
- 👤 Patricia K. Donahoe
- 👤 David A. Swann
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 13:02
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/575; A; A61; A61K; A61K38/00
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
130 words
A purified form of Mullerian Inhibiting Substance (MIS) which, when isolated from testicular tissue comprises a glycoprotein having the following characteristics: (a) an activity of at least 1 as measured by the Mullerian regression organ culture assay, which is substantially free of testicular tissue and of proteinaceous material capable of degrading said MIS; (b) a cytotoxicity index of greater than 0.25 towards synchronously growing cells in a cell culture of a human ovarian papillary serous cystadenocarcinoma, when said cell culture is populated at a density between 50 and 100 cells per well, but showing no statistically significant cytotoxicity towards non-Mullerian human gliobastomas or against human fibroblasts; (c) molecular weight about 70,000 daltons; (d) carbohydrate fraction: mannose, galactose, glucasamine, and N-acetylneuraminic acid; and (e) peptide fraction: 80-90 weight percent amino acids.
Claim 2
Dependent Claim
130 words
A purified form of Mullerian Inhibiting Substance (MIS) which, when isolated from testicular tissue comprises a glycoprotein having the following characteristics: (a) an activity of at least 1 as measured by the Mullerian regression organ culture assay, which is substantially free of testicular tissue and of proteinaceous material capable of degrading said MIS; (b) a cytotoxicity index of greater than 0.25 towards synchronously growing cells in a cell culture of a human ovarian papillary serous cystadenocarcinoma, when said cell culture is populated at a density between 50 and 100 cells per well, but showing no statistically significant cytotoxicity towards non-Mullerian human gliobastomas or against human fibroblasts; (c) molecular weight about 70,000 daltons; (d) carbohydrate fraction: mannose, galactose, glucasamine, and N-acetylneuraminic acid; and (e) peptide fraction: 80-90 weight percent amino acids.
Claim 3
Independent Claim
31 words
A method for inhibiting the growth of human ovarian cancer cells which comprises administering to said cells Mullerian Inhibiting Substance in an amount effective to inhibit the growth of said cells.
Claim 4
Independent Claim
31 words
A method for inhibiting the growth of human ovarian cancer cells which comprises administering to said cells Mullerian Inhibiting Substance in an amount effective to inhibit the growth of said cells.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1994-04-29 | 1994-10-29 | 1995-04-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1998-04-29 | 1998-10-29 | 1999-04-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2002-04-29 | 2002-10-29 | 2003-04-30 | $7700.00 | Window Closed / Lapsed |